phase readout
saveNCT06864026: A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Eli Lilly and Company. Phase: PHASE4. Conditions: Psoriatic Arthritis, Overweight or Obesity
view source ↗
comments(0)
5-min edit window · permanent after that